Skip to Content

Case Overview

Search Import Questions Import Conditions Onshore Outcomes

Case: Human therapeutics and medicines Effective: 18 Mar 2019 to 28 Mar 2019

Case Description

This case describes the requirements for the importation of human therapeutics and medicines. The case may include but is not limited to items such as human antibodies and cell lines, human tissues and fluids, human therapeutics, synthetic or non-synthetic therapeutics or excipients.
For the import of dietary supplements and natural medicines containing ingredients of plant origin, please refer to the BICON case Dietary supplements and natural medicines for human consumption.
For the import of fungi (dried mushroom), including Ganoderma, Poriacoros and Cordyceps, please refer to the BICON case Mushrooms for human consumption.
For the import of slippery elm bark, please refer to the BICON case Powdered plant products for human consumption.
For the import of bee powder or pollen for human therapeutic use, please refer to the BICON case Bee products.

Alerts

2 Active Alert(s) View

This case applies to imports into: Australia.

Warnings and Information Notices
Warning

Some products may require specialised storage and/or handling.